Daten des Robert Koch-Instituts: 7-Tage-Inzidenz & Hospitalisierungen & GrippeWeb-Wochenbericht & AMELAG
Das aktuelle Corona-Krankheitsaufkommen in Deutschland beträgt schätzungsweise 17 Fälle pro 100.000 Einwohner, was bedeutet, dass ca. eine von 4.118 Personen derzeit akut infiziert ist (angenommen sind Ø 10 Tage Infektionsdauer). Das Robert-Koch-Institut (RKI) meldet eine auf meldepflichtigen PCR-Tests basierte Inzidenz von 0, wobei auf jede offiziell registrierte Infektion etwa 161 weitere unentdeckte Fälle entfallen. Informationen zur aktuellen Verteilung zirkulierender SARS-CoV-2-Varianten finden sich im RKI-Dashboard.
Die auf dem GrippeWeb-Wochenbericht basierte Inzidenz aller Atemwegserkrankungen beträgt 3.868 pro 100.000 Einwohner, was bedeutet, dass ca. eine von 26 Personen derzeit akut infiziert ist (angenommen sind Ø 7 Tage Infektionsdauer; Vergleich zu den Vorjahren). Stand: 14.06.2026
Der Risikorechner macht infektiöse Aerosol-Gefahren in Innenräumen sichtbar und unterstützt dabei, das tatsächliche Ansteckungsrisiko realistisch einzuschätzen.
Risiko berechnen
Rund um das Immunsystem gibt es viele Mythen und Missverständnisse. Dieser Text klärt einige häufige Fragen wissenschaftlich fundiert auf.
Weiterlesen
Dynamics of HIV reservoirs following repeated anti-SARS-CoV-2 vaccination 13.06.2026
Development of a recombinant single-cycle influenza viral vector as an intranasal vaccine against SARS-CoV-2 13.06.2026
SARS-CoV-2 memory response in non-hospitalised cases:immunology in the context of a population-based cohort study 13.06.2026
A decoy virus strategy using plant-produced SARS-CoV-2 virus-like-particles to inhibit infection and lung injury 13.06.2026
Rational design and high-yield expression of SARS-CoV-2 nucleocapsid antigen for a sensitive and specific in-house ELISA 13.06.2026
Mixed lineage kinase 3 mediates SARS‐CoV‐2‐induced kidney injury via the Hsp70‐IL‐17A axis 13.06.2026
DNAm landscape up to 4 months post SARS-CoV-2 infection:insights from four population-based cohorts 13.06.2026
The First Record of Obesogammarus crassus (G.O. Sars, 1894) (Amphipoda) in Lake Ilmen 13.06.2026
SARS-CoV-2 ORF3a blocks lysosomal cholesterol egress by disrupting VPS39-regulated NPC2 trafficking and BMP metabolism 13.06.2026
Nanobodies targeting SARS-CoV-2 variants 13.06.2026
Single-cell transcriptomic and immune receptor profiling reveals distinct immune remodeling in SARS-CoV-2 convalescent individuals 13.06.2026
Larger Acute Phase Reactions Are Associated with Immunogenicity of an Adjuvanted Recombinant Receptor Binding Domain Protein Vaccine Against SARS-CoV-2 in Rhesus Monkeys 13.06.2026
Clinical manifestations and laboratory findings in patients coinfected with dengue virus and SARS-CoV-2:a systematic review. 12.06.2026
Reverse genetics strategies for coronaviruses:platform construction and applications in vaccine development. 12.06.2026
Antibody repertoire associated with clinically diverse presentations of pediatric SARS-CoV-2 infection. 12.06.2026
Clinical and genomic characterization of Influenza A co-infection with SARS-CoV-2 and Influenza B:a respiratory surveillance study in Assam, India. 12.06.2026
DAL, lectin from Dioclea altissima:Three-dimensional structure resolution by X-ray diffraction and in silico prospection for targeting Mpro from SARS-CoV-2. 12.06.2026
Performance evaluation of Meso Scale Discovery (MSD) quantitative serological assays for detection of binding (IgG, IgA, IgM) and ACE2 inhibitory antibody levels for SARS-CoV-2. 12.06.2026
Epcoritamab monotherapy or epcoritamab with lenalidomide as first-line therapy for patients with diffuse large B-cell lymphoma (EPCORE DLBCL-3):primary analysis of an open-label, multicentre, randomised, phase 2 trial. 12.06.2026
Seasonal vaccine-induced immunity shows preserved cross-reactivity to H3N2 subclade K in adults. 12.06.2026
Cardiovascular Involvement and Its Association with Disease Severity and Recovery in SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Children. 12.06.2026
Cleavage of TOM1 by the SARS-CoV-2 main protease NSP5 prevents autophagic degradation of viral envelope. 12.06.2026
Substrate-Selective Inhibition of the SARS-CoV-2 Papain-Like Protease:Inhibition of Hydrolysis of Human Over Viral Substrates. 12.06.2026
Discovery and evaluation of a 4-(benzothiazol-2-yl)-N-substituted aniline scaffold as MERS-CoV inhibitors 12.06.2026
DAL, lectin from Dioclea altissima:Three-dimensional structure resolution by X-ray diffraction and in silico prospection for targeting Mpro from SARS-CoV-2 12.06.2026
Long-term Humoral Immune Dynamics After SARS-CoV-2 Vaccination and Infection in Healthcare Workers:The VaCoMRI Study 12.06.2026
The Dynamics of SARS-CoV-2 Virus Infection, Effectiveness of Vaccination and Revaccination with Sputnik V and Sputnik Light Drugs for Non-Specialized Medical Workers during the COVID-19 Pandemic 12.06.2026
CLONING, EXPRESSION AND SECRETION OF SARS-COV2 RECEPTOR BINDING DOMAIN IN P. PASTORIS 12.06.2026
Two-timepoint multidomain follow-up of post-COVID condition and ME/CFS:overlapping autonomic, small-fiber, and cognitive changes 12.06.2026
Cardiovascular Involvement and Its Association with Disease Severity and Recovery in SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Children 12.06.2026
Cleavage of TOM1 by the SARS-CoV-2 main protease NSP5 prevents autophagic degradation of viral envelope 12.06.2026
Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) 12.06.2026
SARS:Selected Appropriate Representation for Sub-tasks in Human-Object Interaction Detection 12.06.2026
ELECTRONIC CIGARETTE IN PANDEMIC CONDITIONS WITH SARS –COV 2 12.06.2026
Opposing Association of Lung Neutrophils and PD‐L1 + Monocytes in Age‐Related Severity of SARS‐CoV‐2 Infection 12.06.2026
Substrate‐Selective Inhibition of the SARS‐CoV‐2 Papain‐Like Protease:Inhibition of Hydrolysis of Human Over Viral Substrates 12.06.2026
Clinical and genomic characterization of Influenza A co-infection with SARS-CoV-2 and Influenza B:a respiratory surveillance study in Assam, India 12.06.2026
Integrated 3D-QSAR, Docking and Molecular Dynamics Reveal Novel Drug-Like Inhibitors of SARS-CoV-2 Main Protease 12.06.2026
Rewiring oncogenic signalling to precision ablation of metastatic cancer 12.06.2026
Genomic Surveillance of SARS‐CoV‐2 in Senegal (2020–2024):Variant Turnover, Omicron Introductions, and Interregional Spread 12.06.2026
Antibody repertoire associated with clinically diverse presentations of pediatric SARS-CoV-2 infection 12.06.2026
A microfluidic SERS platform with magnetic microsphere-AgNWs interfacial synergy for ultrasensitive detection of SARS-CoV-2 nucleic acids 12.06.2026
Performance evaluation of Meso Scale Discovery (MSD) quantitative serological assays for detection of binding (IgG, IgA, IgM) and ACE2 inhibitory antibody levels for SARS-CoV-2 12.06.2026
SARS-CoV-2-host and interactions:the dual roles of E3 ubiquitin ligases and ubiquitin-like modification mechanisms in viral infection 12.06.2026
Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells 12.06.2026
Clinical manifestations and laboratory findings in patients coinfected with dengue virus and SARS-CoV-2:a systematic review 12.06.2026
Integrating Molecular Dynamics Simulation-Driven Computational Validation and In Vitro Biological Assessment of Pteridin-7(8 H )-one-Thiadiazole Hybrids Derivatives as Effective SARS-CoV-2 Main Protease Inhibitors 12.06.2026
Acute and chronic kidney injury following COVID-19 infection and vaccination:a narrative review. 11.06.2026
Trends in Medicaid Administrative Expenditures During the COVID-19 Public Health Emergency. 11.06.2026
Screening of autoinflammatory genes in patients with SARS-CoV-2-associated MIS-C. 11.06.2026
Nosocomial SARS-CoV-2 Infection in Patients with Cancer:A Four-Year Experience From a Tertiary Cancer Center 11.06.2026
Engineering Komagataella phaffii for secreted and surface-displayed production of SARS-CoV-2 receptor-binding domain and its immunogenicity evaluation 11.06.2026
Schizophrenia in relation with coronavirus SARS-CoV2 infection-an epigenetic explanation 11.06.2026
ATIVAÇÃO DO INFLAMASSOMA NLRP3 EM INFECÇÕES CAUSADAS PELO SARS-COV-2 E SUA CORRELAÇÃO COM A GRAVIDADE DA DOENÇA 11.06.2026
Wastewater surveillance of SARS-CoV-2 RNA and detection of emerging viral variants from wastewater in the city of Manila, Philippines 11.06.2026
Empowering Community Psychiatry:A Cross-Sectional Study of the Prevalence of Generalized Anxiety Disorder in an Underserved Venezuelan Population. 09.06.2026
SARS-CoV-2 mRNA XBB1.5 vaccine immunogenicity in kidney transplant recipients. 07.06.2026
N-hydroxy-isocytidine:A direct-acting broad-Spectrum antiviral agent against respiratory viruses with potent activity against MERS-CoV. 06.06.2026
MarkerScout:A Disease-Agnostic Machine Learning Framework for Biomarker Prediction from Multi-Scale Mechanistic Models. 05.06.2026
A phage display library to dissect antibody responses to human coronavirus spike proteins. 05.06.2026
A designed overlapping variant immunogen pool elicits broad sarbecovirus neutralization. 04.06.2026
Systems-Scale Structural Modeling Reveals the Germline Architecture of Immunodominance. 04.06.2026
TNFRSF13B Common Variants Enhance Antibody-Dependent Complement Activation and Susceptibility to Acute Respiratory Distress Syndrome Following Respiratory Viral Infection. 04.06.2026
Functional and structural characterization of the SARS-CoV-2 spike N481K mutation. 04.06.2026
Rationale and Design of RECOVER-ENERGIZE:A Platform Clinical Trial of Interventions for Exercise Intolerance With and Without Post-exertional Malaise in Long COVID. 03.06.2026
A reversible broad-spectrum antiviral targets the human V-ATPase VO domain. 03.06.2026
Using Heart Rate to Measure Stress in Healthcare Workers Wearing PAPRs and N95 Masks:Insights from a Randomized Trial. 03.06.2026
Mitochondrial OXPHOS restricts SARS-CoV-2 replication. 03.06.2026
Chronic cocaine exposure negatively impacts Long-COVID-like outcomes produced by the SARS-CoV-2 spike protein in the rat. 02.06.2026
A Viral Mutation Profiling and Discovery Strategy for Sensitive Multiplex Detection of Viruses and Variants in Saliva by Proteomics. 02.06.2026
Host metabolic responses to SARS-CoV-2 and influenza viruses:parallels and contrasts. 02.06.2026
Chronic Conditions and Mortality in Medicare Beneficiaries Before and After the COVID-19 Pandemic. 01.06.2026
Superior magnitude and durability of hybrid immunity following SARS-CoV-2 infection. 01.06.2026
Whey Proteins and Immunity:Mechanisms Underlying Immune System Reinforcement and Protection Against Viral and Bacterial Infections. 30.05.2026
Pediatric post-acute sequelae of SARS-CoV-2 infection in Taiwan:Insights from the DISCOVER cohort. 29.05.2026
Surface Functionalization Studies in the Development of Nanohole Plasmonic Sensors. 29.05.2026
Ubiquitin ligase ITCH regulates life cycle of SARS-CoV-2 virus. 29.05.2026
Helminth infection modulates the immunogenicity of COVID-19 vaccines in mice without compromising protective efficacy. 28.05.2026
Social and Behavioral Correlates of Self-Perceived Psychological Distress in Celiac Disease During the COVID-19 Pandemic:An Exploratory Cross-Sectional Study (COVIMPACT). 28.05.2026
Cutaneous Lymphomas and Lymphoproliferative Disorders Associated With SARS-CoV-2 Vaccination:A Systematic Review. 28.05.2026
SARS-CoV-2 Spike Protein's Structural Dynamics Affect the Activity of the Bebtelovimab Antibody. 27.05.2026
Cephalosporins are potent SARS-CoV-2 main protease inhibitors. 22.05.2026
Wastewater-based surveillance for SARS-CoV-2 in Alberta 20.05.2026
Validation of a Mucosal IgA Assay for SARS-CoV-2. 20.05.2026
Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution. 18.05.2026
Bioluminescent label-free molecular switch for SARS-CoV-2 detection. 15.05.2026
SARS-CoV-2 and reproductive system:a scientometric study. 14.05.2026
Genetic variability of SARS-CoV-2 in wastewater and associations with community transmission. 14.05.2026
The Effect of Vaccination on the Evolution of the SARS-CoV-2 B.1.351 Variant 08.05.2026
SARS-CoV-2:To transgress or Not? 07.05.2026
Hypertensive Emergency in the Context of SARS-CoV-2 Infection:Clinical Course and Management. 06.05.2026
SARS-CoV-2 Infection and Rates of Neonatal Congenital Anomalies. 01.05.2026
SARS-CoV-2 Variants and Immune Evasion:Mapping the Future of Vaccine Design. 01.05.2026
Widespread SARS-CoV-2 Transmission Despite Limited Reported Cases and Clinical Disease:Exploring the Role of Pre-Existing Humoral Immunity to SARS-CoV-2 in Eastern Sierra Leone. 01.05.2026
SARS-CoV-2 in Pregnancy-More Hints of Rare Complications. 01.05.2026
Recent COVID-19 Vaccination and Risk of SARS-CoV-2 Transmission. 01.05.2026
Evolutionary inferences from the analysis of mutation dynamics in the SARS-CoV-2 replication-transcription complex. 01.05.2026
Impact of the COVID-19 pandemic on primary health care reform in Pakistan. 26.04.2026
Global mobility flows and COVID-19 spread in Europe during the emergency phase:Insights from Meta-Facebook data. 25.04.2026
Genomic and Phylogenetic Dissection of SARS-CoV-2 Transmission Networks in Healthcare Workers. 21.04.2026
Quellen: PubMed, Europe PMC & CrossRef
Post-Covid & ME/CFS: So meistern Sie die Hürden der neuen DGUV-Begutachtung - Anwalt.de 14.06.2026
Covid-Impfstoffdeals: Gutachten sieht Verstoß der EU-Kommission - Journalmed.de 13.06.2026
"Nicht dasselbe Leben wie vor Long Covid": Schriftstellerin Ivna Žic gibt Einblicke - hessenschau.de 12.06.2026
Covid-Impfstoffdeals: Gutachten sieht Verstoß der EU-Kommission - T-Online 11.06.2026
Hier finden Sie ausgezeichnete Rehakliniken für Long-Covid-Erkrankungen - STERN.de 10.06.2026
Antiasiatische Aggressionen: Covid-Rassismus – mehr Wut als Angst - Pharmazeutische Zeitung 10.06.2026
ME/CFS und Post-COVID-Syndrom: Die Beweiskraft der Post-Exertional Malaise (PEM) im Sozial- und Versicherungsrecht - Anwalt.de 10.06.2026
Informationen zu Long-COVID - NN.de 09.06.2026
Greifswald: Neues Forschungsprojekt der Unimedizin zu Long COVID - NDR.de 29.05.2026
Homepage | Eckpunktepapier für die medizinische Rehabilitation bei Post-COVID-Syndrom - Deutsche Rentenversicherung 21.05.2026
Covid-19: Wie gefährlich ist das Coronavirus 2026 noch? - aponet.de 06.05.2026
Warum Long Covid bei Kindern anders ist als bei Erwachsenen - MDR.de 06.05.2026
Falsche Zahlen zu angeblichen Impf-Toten - tagesschau.de 24.04.2026
Rückblick auf die durch Long COVID verlorenen Jahre: Susans Geschichte - World Health Organization (WHO) 16.03.2026
So trainieren sich Post-Covid-Patienten zurück in den Alltag - rbb24.de 16.03.2026
Warken: „Wir wollen die Versorgung von Long-COVID-Betroffenen weiter verbessern“ - Bundesministerium für Gesundheit (BMG) 13.03.2026
Myth-busters- debunking long COVID myths and misconceptions - World Health Organization (WHO) 03.02.2026
Entlarvung von Mythen und falschen Vorstellungen über Long COVID - World Health Organization (WHO) 30.01.2026
Neue Clearingstelle unterstützt Menschen mit gesundheitlichen und wirtschaftlichen Beeinträchtigungen nach einer COVID-19-Schutzimpfung - Ministerium für Arbeit, Gesundheit und Soziales Nordrhein-Westfalen 14.01.2026
Auftakttreffen der „Allianz postinfektiöse Erkrankungen: Long COVID und ME/CFS“ des BMG und BMFTR - Deutsche Gesellschaft für ME/CFS 24.11.2025
Quelle: Google News
Pluslife ist ein Molekulartest (PoC-NAT) für zuhause: besser als Antigen-Schnelltests bei niedriger Viruslast – und mit Analyzer-Webapp von »virus.sucks« werden Ergebnisse nachvollziehbar.
Safe Air Docs hilft dabei, Arztpraxen mit hohen Infektionsschutzstandards zu finden. So wird der Arztbesuch sicherer – besonders für Menschen mit erhöhtem Gesundheitsrisiko.
Am 15. und 16. Mai 2024 fand die virtuelle Konferenz #UniteToFight2024 statt und zog über 10.000 Teilnehmer an, die sich über die neuesten Entwicklungen zu Long Covid und ME/CFS informierten. Führende Experten wie Dr. David Putrino und Prof. Akiko Iwasaki präsentierten aktuelle Forschungsergebnisse.
Die Übertragung durch Aerosole ist einer der am schwierigsten zu vermeidenden Infektionswege, kann aber durch FFP2- und FFP3-Masken effektiv blockiert werden.
2023: Golda Schlaff und 15 weitere prominente Ärzt:innen fordern mehr Respekt vor den Patient:innen, die Wiedereinführung von FFP2-Masken bei steigenden Inzidenzen sowie den flächendeckenden Einsatz von HEPA-Filtern in medizinischen Einrichtungen.